| Current surgical therapy E-book JL Cameron, AM Cameron Elsevier health sciences, 2013 | 604 | 2013 |
| Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma N Agrawal, Y Jiao, C Bettegowda, SM Hutfless, Y Wang, S David, ... Cancer discovery 2 (10), 899-905, 2012 | 407 | 2012 |
| Predictors of outcomes of COVID-19 in patients with chronic liver disease: US multi-center study D Kim, N Adeniji, N Latt, S Kumar, PP Bloom, ES Aby, P Perumalswami, ... Clinical Gastroenterology and Hepatology 19 (7), 1469-1479. e19, 2021 | 236 | 2021 |
| Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infection KV Kowdley, V Sundaram, CY Jeon, K Qureshi, NL Latt, A Sahota, S Lott, ... Hepatology 65 (4), 1094-1103, 2017 | 90 | 2017 |
| Liver injury in liver transplant recipients with coronavirus disease 2019 (COVID‐19): US multicenter experience A Rabiee, B Sadowski, N Adeniji, PV Perumalswami, V Nguyen, A Moghe, ... Hepatology 72 (6), 1900-1911, 2020 | 87 | 2020 |
| Hepatitis C virus and its renal manifestations: a review and update N Latt, N Alachkar, A Gurakar Gastroenterology & hepatology 8 (7), 434, 2012 | 75 | 2012 |
| Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov. 2012; 2: 899–905. doi: 10.1158/2159-8290 N Agrawal, Y Jiao, C Bettegowda, SM Hutfless, Y Wang, S David, ... CD-12-0189.[Europe PMC free article][Abstract][CrossRef][Academic Search], 0 | 46 | |
| Liver transplant allocation policies and outcomes in United States: a comprehensive review NL Latt, M Niazi, NT Pyrsopoulos World journal of methodology 12 (1), 32, 2022 | 42 | 2022 |
| Expanding indications for liver transplantation in the era of liver transplant oncology G Panayotova, KE Lunsford, NL Latt, F Paterno, JV Guarrera, ... World journal of gastrointestinal surgery 13 (5), 392, 2021 | 28 | 2021 |
| Provider attitudes toward risk-based hepatocellular carcinoma surveillance in patients with cirrhosis in the United States NJ Kim, K Rozenberg-Ben-Dror, DA Jacob, NE Rich, AG Singal, ES Aby, ... Clinical Gastroenterology and Hepatology 20 (1), 183-193, 2022 | 23 | 2022 |
| Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis C genotype-1 patients with hepatitis C virus-RNA< 6 million: Single center, real world … NL Latt, BT Yanny, D Gharibian, R Gevorkyan, AK Sahota World Journal of Gastroenterology 23 (26), 4759, 2017 | 23 | 2017 |
| Real-world experiences with a direct-acting antiviral agent for patients with hepatitis C virus infection V Louie, NL Latt, D Gharibian, A Sahota, BT Yanny, R Mittal, ... The Permanente Journal 21, 2017 | 21 | 2017 |
| A Cohort Study for the Derivation and Validation of a Clinical Prediction Scale for Hospital‐Onset Clostridium difficile Infection S Chandra, N Latt, U Jariwala, V Palabindala, R Thapa, ... Canadian Journal of Gastroenterology and Hepatology 26 (12), 885-888, 2012 | 21 | 2012 |
| Risk of hepatitis B virus reactivation among patients treated with ledipasvir-sofosbuvir for hepatitis C virus infection BT Yanny, NL Latt, S Saab, S Han, G Choi, J Kramer, AK Sahota Journal of Clinical Gastroenterology 52 (10), 908-912, 2018 | 18 | 2018 |
| Provider attitudes and practice patterns for direct-acting antiviral therapy for patients with hepatocellular carcinoma NE Rich, JD Yang, PV Perumalswami, N Alkhouri, W Jackson, ND Parikh, ... Clinical Gastroenterology and Hepatology 18 (4), 974-983, 2020 | 17 | 2020 |
| Socioeconomic factors contribute to the higher risk of COVID-19 in racial and ethnic minorities with chronic liver diseases N Adeniji, RM Carr, ES Aby, AM Catana, K Wegermann, R Dhanasekaran Gastroenterology 160 (4), 1406, 2020 | 15 | 2020 |
| Current management of alcohol-associated liver disease FA Siddiqi, KC Sajja, NL Latt Gastroenterology & Hepatology 16 (11), 561, 2020 | 12 | 2020 |
| Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov. 2, 899–905 N Agrawal, Y Jiao, C Bettegowda, SM Hutfless, Y Wang, S David, ... | 10 | 2012 |
| Update on the management of hepatitis C virus infection in the setting of chronic kidney disease and kidney transplantation NL Latt Gastroenterology & Hepatology 14 (12), 687, 2018 | 9 | 2018 |
| Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study ES Aby, G Moafa, N Latt, MT Sultan, PA Cacioppo, S Kumar, RT Chung, ... Hepatology communications 7 (1), e8874, 2023 | 8 | 2023 |
Nada Alachkar, MD.Associate Professor of Medicine. Johns Hopkins University School of MedicineBestätigte E-Mail-Adresse bei jhmi.edu
